Intellect Neurosciences Inc. (fka ILNS)

[KaOsiris]

OTC Markets Group Welcomes Newly Verified OTCQB Companies – April 14
Apr 14, 2015

OTC Disclosure & News Service

New York, NY -
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced the following companies are verified for trading on the OTCQB® Venture Marketplace:

....

Intellect Neurosciences, Inc. (OTCQB: ILNS) – Intellect Neurosciences is a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of neurodegenerative conditions, especially proteinopathies. These conditions include Alzheimer’s disease, Parkinson’s and Huntington’s disease, Frontotemporal Dementia and age related macular degeneration. The company’s internal drug discovery programs are focused on the therapeutic applications of monoclonal antibodies and antibody-drug conjugates. Intellect has granted licenses to global pharmaceutical companies covering several of the patents in its intellectual property portfolio, which will entitle the company to significant milestone payments and sales based royalties upon successful development and commercialization of the licensed drug candidates.